What is the significance of an isolated positive cryptococcal antigen in the cerebrospinal fluid of cancer patients?

Mycoses

Volumn 46, Issue 5-6, 2003, Pages 161-163

  Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antigen test; Cancer patients; Cryptococcus neoformans; CSF

Indexed keywords

FUNGUS ANTIGEN;

ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER PATIENT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CRYPTOCOCCUS NEOFORMANS; FEMALE; FUNGUS ISOLATION; HUMAN; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGGLUTINATION; ANTIGENS, FUNGAL; CHILD; CRYPTOCOCCUS NEOFORMANS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REAGENT KITS, DIAGNOSTIC;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0038391251     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2003.00877.x     Document Type: Article

References (5)

1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-48.
2. Kontoyiannis DP, Peitsch WK, Reddy BT et al. Cryptococcosis in patients with cancer. Clin Infect Dis 2001; 32: e145-50.
3. Stockman L, Roberts GD. Specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors. J Clin Microbiol 1982; 16: 965-967.
4. Hopfer RL, Perry EV, Fainstein V. Diagnostic value of cryptococcal antigen in the cerebrospinal fluid of patients with malignant disease. J Infect Dis 1982; 145: 915.
5. McManus EJ, Jones JM. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol 1985; 21: 681-5.